(Q24235775)

title

Oral vaccines for preventing cholera (English)

0 references

0 references

5

Patricia M Graves

Patricia M

Graves

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532691&resulttype=core&format=json

14 May 2020

4

Firdausi Qadri

Firdausi

Qadri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532691&resulttype=core&format=json

14 May 2020

1

David Sinclair

David

Sinclair

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532691&resulttype=core&format=json

14 May 2020

K Zaman

3

K

Zaman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532691&resulttype=core&format=json

14 May 2020

Katharine Abba

series ordinal

2

author given names

Katharine

author last names

Abba

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532691&resulttype=core&format=json

Cochrane Database of Systematic Reviews

14 May 2020

publication date

16 March 2011

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532691&resulttype=core&format=json

14 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532691&resulttype=core&format=json

14 May 2020

page(s)

CD008603

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532691&resulttype=core&format=json

Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama.

14 May 2020

cites work

1 reference

12 December 2020

Mucosal vaccination strategies for women

1 reference

12 December 2020

Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit.

1 reference

12 December 2020

Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination

1 reference

12 December 2020

Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139

1 reference

12 December 2020

Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children

1 reference

12 December 2020

Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report).

1 reference

12 December 2020

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

1 reference

12 December 2020

Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru

1 reference

12 December 2020

Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adults

1 reference

12 December 2020

Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR

1 reference

12 December 2020

A comparison of the serological effects of classical cholera vaccine and of purified fraction vaccine, with or without simultaneous yellow fever vaccine (author's transl)

1 reference

12 December 2020

Vaccines for preventing cholera

1 reference

12 December 2020

Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR.

1 reference

12 December 2020

Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine

1 reference

12 December 2020

Misleading negative findings in a field trial of killed, oral cholera vaccine in Peru

1 reference

12 December 2020

Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine

1 reference

12 December 2020

Human gastric B cell responses can be induced by intestinal immunisation

1 reference

12 December 2020

Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans

1 reference

12 December 2020

A human volunteer challenge model using frozen bacteria of the new epidemic serotype, V. cholerae O139 in Thai volunteers

1 reference

12 December 2020

Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.

1 reference

12 December 2020

Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine

1 reference

12 December 2020

Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants

1 reference

12 December 2020

Antibody response to two cholera vaccines in volunteers

1 reference

12 December 2020

Sample size determination for phase II studies of new vaccines

1 reference

12 December 2020

Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children.

1 reference

12 December 2020

Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine

1 reference

12 December 2020

Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18–36 months of age

1 reference

12 December 2020

Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation

1 reference

12 December 2020

Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children

1 reference

12 December 2020

Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial

1 reference

12 December 2020

Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area

1 reference

12 December 2020

FIELD TRIAL OF CHOLERA VACCINE IN RURAL EAST PAKISTAN. FIRST YEAR OF OBSERVATION

1 reference

12 December 2020

Suppressive effect of zinc on antibody response to cholera toxin in children given the killed, B subunit-whole cell, oral cholera vaccine

2 references

12 December 2020

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD008603.PUB2

7 January 2021

An oral B subunit: whole cell vaccine against cholera

1 reference

12 December 2020

1 reference

12 December 2020

Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults

1 reference

12 December 2020

Comparison of different routes of vaccination for eliciting antibody responses in the human stomach

1 reference

12 December 2020

Can oral cholera vaccination play a role in controlling a cholera outbreak?

1 reference

12 December 2020

Onset and Duration of Protective Immunity in Challenged Volunteers after Vaccination with Live Oral Cholera Vaccine CVD l03-HgR

1 reference

12 December 2020

Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers

1 reference

12 December 2020

[Dukoral. Oral vaccine against cholera]

1 reference

12 December 2020

1 reference

12 December 2020

Effectiveness of mass oral cholera vaccination in Beira, Mozambique

1 reference

12 December 2020

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA

1 reference

12 December 2020

Kinetics of local and systemic immune responses after vaginal immunization with recombinant cholera toxin B subunit in humans

1 reference

12 December 2020

Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand

1 reference

12 December 2020

The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers

1 reference

12 December 2020

Nonparticipation as a determinant of adverse health outcomes in a field trial of oral cholera vaccines

1 reference

12 December 2020

Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis

1 reference

12 December 2020

Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh

1 reference

12 December 2020

Clinical and bacteriological studies of El Tor cholera after ingestion of known inocula in Thai volunteers

1 reference

12 December 2020

Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity

1 reference

12 December 2020

Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groups

1 reference

12 December 2020

Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique

1 reference

12 December 2020

Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children

1 reference

12 December 2020

Influence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans

1 reference

12 December 2020

A review of vaccine research and development: human enteric infections

1 reference

12 December 2020

Efficacy calculation in randomized trials: global or local measures?

2 references

12 December 2020

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD008603.PUB2

7 January 2021

Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam

1 reference

12 December 2020

Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries

1 reference

12 December 2020

Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunity.

1 reference

12 December 2020

Oral cholera vaccines: use in clinical practice

1 reference

12 December 2020

Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

1 reference

12 December 2020

1 reference

12 December 2020

Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants.

1 reference

12 December 2020

Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.

1 reference

12 December 2020

In vivo evidence of immunological masking of the Vibrio cholerae O antigen of a hybrid Salmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans

1 reference

12 December 2020

Present and future cholera vaccines

1 reference

12 December 2020

The characteristics of the reactogenicity and immunological activity of a new cholera bivalent chemical vaccine based on the results of controlled trials

1 reference

12 December 2020

Using a fingerprint recognition system in a vaccine trial to avoid misclassification

1 reference

12 December 2020

Private demand for cholera vaccines in Beira, Mozambique

1 reference

12 December 2020

Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum

1 reference

12 December 2020

The Antibody Response to an Oral Ty21a-Based Typhoid-Cholera Hybrid Is Unaffected by Prior Oral Vaccination with Ty21a

1 reference

12 December 2020

Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.

1 reference

12 December 2020

Private demand for cholera vaccines in rural Matlab, Bangladesh

1 reference

12 December 2020

Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera

1 reference

12 December 2020

Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.

1 reference

12 December 2020

Risk factors for cholera in Pohnpei during an outbreak in 2000: lessons for Pacific countries and territories.

1 reference

12 December 2020

Private demand for cholera vaccines in Hue, Vietnam

1 reference

12 December 2020

Cholera vaccines for the developing world.

1 reference

12 December 2020

Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial.

1 reference

12 December 2020

A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India

1 reference

12 December 2020

Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh

1 reference

12 December 2020

Spatial and environmental connectivity analysis in a cholera vaccine trial

1 reference

12 December 2020

Cholera, Zimbabwe--update

1 reference

12 December 2020

Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response

1 reference

12 December 2020

Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults

1 reference

12 December 2020

Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial

1 reference

12 December 2020

Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial

1 reference

12 December 2020

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Immunogenicity of two formulations of oral cholera vaccines in Thai volunteers

1 reference

12 December 2020

Cholera vaccines: WHO position paper

1 reference

12 December 2020

Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera.

1 reference

12 December 2020

Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected)

1 reference

12 December 2020

Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults

1 reference

12 December 2020

[The determination of the optimal inoculation dose of an oral cholera chemical bivalent vaccine in a controlled experiment]

1 reference

12 December 2020

Outbreak news. Cholera, Haiti – update

1 reference

12 December 2020

The cholera pandemic, still with us after half a century: time to rethink

1 reference

12 December 2020

The case for reactive mass oral cholera vaccinations

1 reference

12 December 2020

Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.

1 reference

12 December 2020

A double-blind, controlled trial of bioflorin (Streptococcus faecium SF68) in adults with acute diarrhea due to Vibrio cholerae and enterotoxigenic Escherichia coli.

1 reference

12 December 2020

Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines

1 reference

12 December 2020

Controlled clinical trial of adjuvant immunotherapy with BCG and neuraminidase-treated autologous tumour cells in large bowel cancer

1 reference

12 December 2020

ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy

1 reference

12 December 2020

Oral immunization against cholera

1 reference

12 December 2020

Oral cholera vaccines containing B-subunit-killed whole cells and killed whole cells only. II. Field evaluation of cross-protection against other members of the Vibrionaceae family.

1 reference

12 December 2020

Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine.

1 reference

12 December 2020

Comparison of the reactivities and immunogenicities of procholeragenoid and the B subunit of cholera toxin in Thai volunteers.

1 reference

12 December 2020

Oral cholera vaccines containing B-subunit-killed whole cells and killed whole cells only. I. Cross-reacting antigens of members of family Vibrionaceae and the vaccines

1 reference

12 December 2020

Exclusion of clinically atypical or microbiologically mixed diarrhoeal episodes from outcome events in a field trial of oral cholera vaccines

1 reference

12 December 2020

Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults

1 reference

12 December 2020

Field trial of oral cholera vaccines in Bangladesh

1 reference

12 December 2020

Impact of B subunit killed whole-cell and killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera

1 reference

12 December 2020

Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

1 reference

12 December 2020

Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin.

1 reference

12 December 2020

Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial

1 reference

12 December 2020

Field trial of oral cholera vaccines in Bangladesh

1 reference

12 December 2020

Reactogenicity and immunogenicity of oral cholera vaccine in Thai volunteers.

1 reference

12 December 2020

Intracutaneous vaccination technic with less side effects against typhoid and cholera

1 reference

12 December 2020

Intestinal secretory antibody response induced by an oral cholera vaccine in human volunteers

1 reference

12 December 2020

Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques

1 reference

12 December 2020

Five-year immunologic memory in Swedish volunteers after oral cholera vaccination.

1 reference

12 December 2020

Field Trial of Oral Cholera Vaccines in Bangladesh: Results of One Year of Follow-Up

1 reference

12 December 2020

Effect of neutralization of gastric acid on immune responses to an oral B subunit, killed whole-cell cholera vaccine

1 reference

12 December 2020

Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease

1 reference

12 December 2020

B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity.

1 reference

12 December 2020

Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin

1 reference

12 December 2020

A controlled field trial of plain and aluminium hydroxide-adsorbed cholera vaccines in Surabaya, Indonesia, during 1973--75

1 reference

12 December 2020

Reactogenicity and immunological effectiveness of an oral cholera chemical vaccine in a limited controlled experiment with human revaccination

1 reference

12 December 2020

Efficacy of vaccination of family contacts of cholera cases

1 reference

12 December 2020

Live oral cholera vaccine: evaluation of the clinical effectiveness of two strains in humans

1 reference

12 December 2020

Report of the 1966-67 cholera vaccine trial in rural East Pakistan

1 reference

12 December 2020

A controlled field trial of the effectiveness of monovalent classical and El Tor cholera vaccines in the Philippines

1 reference

12 December 2020

A controlled field trial on the effectiveness of the intradermal and subcutaneous administration of cholera vaccine in the Philippines

1 reference

12 December 2020

Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observation

1 reference

12 December 2020

[Study of the immunogenicity and immunological effectiveness of choleragen anatoxin (data from a controlled epidemiological experiment). I. The characteristics of choleragen anatoxin compared wiht corpuscular cholera vaccines administered by syringe

1 reference

12 December 2020

[Study of the immunogenicity and immunological effectiveness of choleragen anatoxin (data from a controlled epidemiological experiment). II. The cahracterisitcs of choleragen anatoxin immunogenicity compared with corpuscular cholera vaccines adminis

1 reference

12 December 2020

The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests

1 reference

12 December 2020

Cholera incidence in a population offered cholera vaccination: comparison of cooperative and uncooperative groups

1 reference

12 December 2020

A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines. Preliminary report; Philippines Cholera Committee

1 reference

12 December 2020

A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines

1 reference

12 December 2020

Controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in Calcutta

1 reference

12 December 2020

Cholera vaccine field trials in east Pakistan. 1. Reaction and antigenicity studies

1 reference

12 December 2020

Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field

1 reference

12 December 2020

A serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the innunized and control populationd of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate

1 reference

12 December 2020

A controlled field trial of the effectiveness of various doses of cholera El Tor vaccine in the Philippines

1 reference

12 December 2020

Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. I. Study design and results of the first year of observation

1 reference

12 December 2020

Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population--the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cho

1 reference

12 December 2020

Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 3. The lack of effect of prior vaccination or circulating vibriocidal antibody on the severity of clinical cholera

1 reference

12 December 2020

Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes.

1 reference

12 December 2020

Initial controlled clinical trials of an oral anticholera vaccine during the cholera epidemic in the district of Malemba-Nkulu (Shaba-Zaire)

1 reference

12 December 2020

Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine

1 reference

12 December 2020

Gut mucosal, salivary and serum antitoxic and antibacterial antibody responses in Swedes after oral immunization with B subunit-whole cell cholera vaccine

1 reference

12 December 2020

Antibody responses to live and killed poliovirus vaccines in the milk of Pakistani and Swedish women

1 reference

12 December 2020

A controlled field trial of an aluminum phosphate-adsorbed cholera vaccine in Calcutta.

1 reference

12 December 2020

Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1

1 reference

12 December 2020

Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines

1 reference

12 December 2020

Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge

2 references

12 December 2020

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD008603.PUB2

7 January 2021

Community-based assessment of safety and immunogenicity of the whole cell plus recombinant B subunit (WC/rBS) oral cholera vaccine in Peru

1 reference

12 December 2020

Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype

1 reference

12 December 2020

Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O

1 reference

12 December 2020

Antibody response in the intestinal secretions of volunteers immunized with various cholera vaccines

1 reference

12 December 2020

Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O.

1 reference

12 December 2020

Cholera vaccine: developmental strategies and problems

1 reference

12 December 2020

Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults

1 reference

12 December 2020

Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits.

1 reference

12 December 2020

Comparative study of reactions and serological response to cholera vaccines in a controlled field trial conducted in the USSR

1 reference

12 December 2020

Development of a live, oral, attenuated vaccine against El Tor cholera

1 reference

12 December 2020

Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers.

1 reference

12 December 2020

[The determination of the optimal inoculation dose of an oral cholera bivalent chemical vaccine in a controlled trial of the vaccination of children and adolescents]

1 reference

12 December 2020

Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers

1 reference

12 December 2020

Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine

1 reference

12 December 2020

Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children

1 reference

12 December 2020

Immunologic response to oral cholera vaccination in a crossover study: a novel placebo effect

1 reference

12 December 2020

[Tolerance and immunogenicity of an oral dose of CVD 103-HgR, a live attenuated Vibrio cholerae 01 strain: a double-blind study of Chilean adults]

1 reference

12 December 2020

Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels

1 reference

12 December 2020

Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection

1 reference

12 December 2020

Circulating cellular immune response to oral immunization of humans with cholera toxin B-subunit

1 reference

12 December 2020

Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers

1 reference

12 December 2020

Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera.

1 reference

12 December 2020

Immunological response to Vibrio cholerae O1 infection and an oral cholera vaccine among Peruvians

1 reference

12 December 2020

Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia

1 reference

12 December 2020

Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.

1 reference

12 December 2020

Local intravaginal vaccination of the female genital tract

1 reference

12 December 2020

Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up

1 reference

12 December 2020

Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine

1 reference

12 December 2020

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam

1 reference

12 December 2020

Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine

1 reference

12 December 2020

Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.

1 reference

12 December 2020

Evaluation of Peru-15, a new live oral vaccine for cholera, in volunteers

1 reference

12 December 2020

1 reference

12 December 2020

Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru

1 reference

12 December 2020

[Community trial for safety and immunogenicity of oral-administered lyophilized rBS-WC cholera vaccine]

1 reference

12 December 2020

Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection

1 reference

12 December 2020

Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults

1 reference

12 December 2020

Kinetics of local and systemic immune responses to an oral cholera vaccine given alone or together with acetylcysteine

1 reference

12 December 2020

Immunogenicity of liposome-associated and refined antigen oral cholera vaccines in Thai volunteers

1 reference

12 December 2020

Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines.

1 reference

12 December 2020

Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine

1 reference

12 December 2020

A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali

1 reference

12 December 2020

Duration of protective immunity conferred by maternal tetanus toxoid immunization: further evidence from Matlab, Bangladesh

1 reference

12 December 2020

Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers

1 reference

12 December 2020

Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans

1 reference

12 December 2020

Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin

1 reference

12 December 2020

Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group

1 reference

12 December 2020

Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.

1 reference

12 December 2020

https://api.crossref.org/works/10.1002%2F14651858.CD008603.PUB2

1 reference

7 January 2021

10.1002/14651858.CD008603.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

2187701

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532691&resulttype=core&format=json

release_6odvvaotl5c4dkpmksjw6gyzqu

14 May 2020

Fatcat ID

0 references

2187701

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532691&resulttype=core&format=json

14 May 2020

PubMed publication ID

21412922

2 references

Consolidated OpenCitations Corpus – April 2017

2187701